Factor VIII inhibitor bypass activity (FEIBA) for the reduction of transfusion in cardiac surgery: a randomized, double-blind, placebo-controlled, pilot trial.
Valerie A SeraAnn E StevensHoward K SongVictor M RodriguezFrederick A TibayanMiriam M TreggiariPublished in: Pilot and feasibility studies (2021)
ClinicalTrials.gov, NCT02577614 . Registered 16 October 2015.